1
|
Oyemade KA, Xu TT, Lopez Dominguez J, Dumbrava MG, Hodge DO, White LJ, Dalvin LA. Population-based incidence of intraocular tumours in Olmsted County, Minnesota. Br J Ophthalmol 2023; 107:1369-1376. [PMID: 35450938 PMCID: PMC10350913 DOI: 10.1136/bjophthalmol-2021-320682] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2021] [Accepted: 04/12/2022] [Indexed: 11/04/2022]
Abstract
BACKGROUND/AIMS To determine population-based incidence of intraocular tumours in Olmsted County, Minnesota. METHODS Record review of the Rochester Epidemiology Project medical record linkage system from 1 January 2006 to 31 December 2015 for patient demographics, tumour type by clinical diagnosis and presence or absence of confirmation by histopathology. The incidence rate of any intraocular tumour and of each tumour type was calculated per million person-years. Poisson regression analysis was used to analyse changes in incidence over time. RESULTS There were 948 patients diagnosed with intraocular tumours resulting in an age-adjusted and sex-adjusted incidence rate of 727.5 per million (95% CI: 680.8 to 774.2, p<0.05). Most tumours were benign (953, 98%). Of the benign lesions, melanocytic lesions were the majority (942, 97%), with adjusted incidence rates of 646.9 (95% CI: 602.8 to 691.1) for choroidal nevus and 55.8 (95% CI: 43.2 to 64.8) for iris nevus. Malignant lesions were rare (16, 2%) with 13 cases of choroidal melanoma and 1 case each of iris melanoma, retinal leukaemic infiltration and metastasis. The adjusted incidence rate for choroidal melanoma was 7.1 (95% CI: 2.5 to 11.8). CONCLUSION In a population-based setting, most intraocular tumours are benign and melanocytic. Although malignant lesions are less common, it is important to remain vigilant with appropriate monitoring given the potential for vision loss and life-threatening malignancy.
Collapse
Affiliation(s)
| | - Timothy T Xu
- Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA
| | | | | | - David O Hodge
- Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida, USA
| | - Launia J White
- Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida, USA
| | - Lauren A Dalvin
- Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA
| |
Collapse
|
2
|
Melendez-Moreno A, Yeşiltaş YS, Wrenn J, Singh AD. Iris melanoma: Prognostication for metastasis. Surv Ophthalmol 2023; 68:957-963. [PMID: 37207703 DOI: 10.1016/j.survophthal.2023.05.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2023] [Revised: 05/10/2023] [Accepted: 05/15/2023] [Indexed: 05/21/2023]
Abstract
Uveal melanoma prognostication studies have mainly included posterior uveal melanomas located in the ciliary body and choroid, often excluding iris melanoma. In this study, we report prognostic status and survival outcomes in a series of 35 patients with biopsy-proven iris melanoma. Fluorescence in situ hybridization was performed in 10 (29%) cases and 2 (5%) underwent multiplex ligation-dependent probe amplification. In total, 9 cases demonstrated disomy 3, 2 cases with monosomy 3 (fluorescence in situ hybridization), and 1 had a technical failure. On gene expression profile testing, 20 of the 23 cases (90%) were gene expression profile class 1A, and the remaining 3 (10%) were class 1B. No patient had a Class 2 status. The median follow-up period was 49 months (mean 59, range 2-156 months). No metastasis was reported during follow-up, and metastasis-free survival was 100%. A review of the published literature revealed 47 cases with high-risk status on molecular prediction, of which only 6 (13%) developed metastasis. Ciliary body involvement was reported in 5 cases and was unknown in 2 cases. We conclude that molecular prognostication of iris melanoma demonstrates low-risk prognostic status in the majority of cases irrespective of the technique used. Even those with high-risk status do not develop metastasis unless the tumor involves the ciliary body.
Collapse
Affiliation(s)
| | - Yağmur Seda Yeşiltaş
- Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA
| | - Jacquelyn Wrenn
- Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA
| | - Arun D Singh
- Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.
| |
Collapse
|
3
|
Shukla AG, Vaidya S, Yaghy A, Di Nicola M, Kaliki S, Fulco E, Myers JS, Shields JA, Shields CL. Iris melanoma: factors predictive of post-management secondary glaucoma in 271 cases at a Single Ocular Oncology Centre. Eye (Lond) 2023; 37:938-946. [PMID: 35383310 PMCID: PMC10050146 DOI: 10.1038/s41433-022-02051-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2021] [Revised: 02/26/2022] [Accepted: 03/22/2022] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND/AIMS To identify factors predictive of post-management secondary glaucoma in eyes with iris melanoma. METHODS Patients with iris melanoma who were conservatively managed on the Ocular Oncology Service, Wills Eye Hospital from 1970 to 2016 were included. Charts were retrospectively reviewed, and binary logistic regression analysis was performed. Main outcome measures were factors predictive of post-management glaucoma, defined as intraocular pressure (IOP) > 22 mmHg following melanoma treatment. RESULTS Of 271 patients with iris melanoma, melanoma-related glaucoma was identified in 40 (15%) at presentation and post-management glaucoma developed in 75 (28%) at a mean of 103.7 months (range:1.0-120.0). Comparison (post-management glaucoma vs. no glaucoma) revealed patients with post-management glaucoma presented with worse visual acuity (20/50-20/150) (17% vs. 5%, p = 0.001), increased mean tumour basal diameter (5.1 mm vs. 4.3 mm, p = 0.004), greater melanoma-related increased IOP on presentation (24.1 mmHg vs. 16.2 mmHg, p < 0.001), diffuse tumour shape (9% vs. 4%, p = 0.01), American Joint Committee on Cancer (AJCC) T4 category (7% vs. 2%, p = 0.03), and extraocular tumour extension (7% vs. 2%, p = 0.03). Risk factors for post-management glaucoma identified by multivariate analysis included melanoma-related increased IOP at presentation (OR:1.1, [1.08-1.22] per 1-mmHg increase, p < 0.001), increased mean tumour basal diameter (OR:1.17, [1.02-1.33] per 1-millimetre increments, p = 0.03), advanced AJCC clinical T subcategory (OR:1.23, [1.04-1.46] per 1-subcategory increments, p = 0.02) and plaque radiotherapy treatment (OR:2.32, [1.13-4.75], p = 0.02). CONCLUSION Features of iris melanoma that predicted post-management glaucoma included melanoma-related increased IOP on presentation, advanced AJCC clinical T subcategory, increased mean tumour basal diameter, and plaque radiotherapy treatment.
Collapse
Affiliation(s)
- Aakriti Garg Shukla
- Glaucoma Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, 11th Floor, Philadelphia, PA, 19107, USA.
- Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
| | - Sarangdev Vaidya
- Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, 14th Floor, Philadelphia, PA, 19107, USA
| | - Antonio Yaghy
- Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, 14th Floor, Philadelphia, PA, 19107, USA
| | - Maura Di Nicola
- Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, 14th Floor, Philadelphia, PA, 19107, USA
| | - Swathi Kaliki
- Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, 14th Floor, Philadelphia, PA, 19107, USA
| | - Enzo Fulco
- Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, 14th Floor, Philadelphia, PA, 19107, USA
| | - Jonathan S Myers
- Glaucoma Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, 11th Floor, Philadelphia, PA, 19107, USA
- Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, 19107, USA
| | - Jerry A Shields
- Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, 19107, USA
- Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, 14th Floor, Philadelphia, PA, 19107, USA
| | - Carol L Shields
- Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, 19107, USA
- Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, 14th Floor, Philadelphia, PA, 19107, USA
| |
Collapse
|
4
|
Gupta K, Kaushik S, Singh AK. Easy Miss: Early Cogan Reese Syndrome. Ophthalmol Glaucoma 2022; 5:657. [PMID: 36127273 DOI: 10.1016/j.ogla.2022.08.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2022] [Revised: 08/10/2022] [Accepted: 08/11/2022] [Indexed: 06/15/2023]
Affiliation(s)
- Kajree Gupta
- Advanced Eye Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India
| | - Sushmita Kaushik
- Advanced Eye Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India
| | - Ashok Kumar Singh
- Advanced Eye Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India
| |
Collapse
|
5
|
Bouirig K, Cherkaoui LO. Nodules de lisch: marqueur ophtalmologique de la neurofibromatose de type 1. Pan Afr Med J 2022; 42:108. [PMID: 36034030 PMCID: PMC9392011 DOI: 10.11604/pamj.2022.42.108.35079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2022] [Accepted: 04/27/2022] [Indexed: 11/24/2022] Open
Affiliation(s)
- Kawtar Bouirig
- Ophthalmology Department “A”, Ibn Sina University Hospital (Hôpital des Spécialités), Mohammed V University, Rabat, Morocco
- Corresponding author: Kawtar Bouirig, Ophthalmology Department “A”, Ibn Sina University Hospital (Hôpital des Spécialités), Mohammed V University, Rabat, Morocco.
| | - Lalla ouafae Cherkaoui
- Ophthalmology Department “A”, Ibn Sina University Hospital (Hôpital des Spécialités), Mohammed V University, Rabat, Morocco
| |
Collapse
|
6
|
Matsunaga D, Williams BK, Desai KB, Shields CL. Extensive "stalagmite" epi-iridic juvenile xanthogranuloma simulating diffuse melanoma in a 16-year-old girl. J AAPOS 2020; 24:253-255. [PMID: 32621982 DOI: 10.1016/j.jaapos.2020.04.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/02/2020] [Revised: 04/17/2020] [Accepted: 04/17/2020] [Indexed: 11/18/2022]
Abstract
A 16-year-old girl noted worsening redness and photophobia of the right eye that had previously been treated unsuccessfully with sequential courses of topical antibiotics and topical corticosteroids. Clinical examination revealed diffuse flakelike thickening of the iris surface, pupillary margin, and anterior chamber angle, suggesting diffuse iris melanoma. Anterior segment optical coherence tomography depicted the mass as an epi-iridic deposit with "stalagmite" surface appearance. Fine-needle aspiration biopsy confirmed an atypical histiocytic proliferative disorder consistent with juvenile xanthogranuloma. Aggressive topical corticosteroid treatment was started. There were no systemic findings. Following therapy, the lesion resolved completely.
Collapse
Affiliation(s)
- Douglas Matsunaga
- Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania
| | - Basil K Williams
- Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania; Department of Ophthalmology, University of Cincinnati College of Medicine, Cincinnati, Ohio
| | - Komal B Desai
- Department of Ophthalmology, University of Missouri, Kansas City School of Medicine, Kansas City
| | - Carol L Shields
- Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
| |
Collapse
|
7
|
|
8
|
|
9
|
|
10
|
|
11
|
Cantón I, Eves PC, Szabo M, Vidal-Vanaclocha F, Sisley K, Rennie IG, Haycock JW, MacNeil S. Tumor necrosis factor alpha increases and alpha-melanocyte-stimulating hormone reduces uveal melanoma invasion through fibronectin. J Invest Dermatol 2003; 121:557-63. [PMID: 12925215 DOI: 10.1046/j.1523-1747.2003.12417.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Iris melanomas are less likely to metastasize than posterior compartment melanomas. The anterior chamber of the eye is an immunosuppressed microenvironment where a wide range of immunosuppressive factors in aqueous humor contribute to the immune privilege. One such factor is alpha-melanocyte-stimulating hormone, a potent anti-inflammatory neuropeptide that exhibits efficacy in many studies of acute and chronic inflammation. The aim of this study was to investigate whether the different metastatic behavior of iris melanomas versus posterior compartment melanomas might be explained by the differing immunosuppressive/anti-inflammatory environments of these tumors in vivo. To investigate this hypothesis, we studied the effect of human aqueous and vitreous fluids, of the proinflammatory cytokine tumor necrosis factor alpha, and of the anti-inflammatory peptides alpha-melanocyte-stimulating hormone and melanocyte-stimulating hormone 11-13 (KP-D-V) on the invasion of three human uveal melanoma cell lines through human fibronectin. Fresh aqueous humor samples significantly decreased the invasion in two out of three uveal melanoma cell lines. In contrast, vitreous humor did not reduce invasion. Tumor necrosis factor alpha significantly increased the invasiveness of uveal melanoma cell lines by approximately 50%-80% over 20 h. Full-length alpha-melanocyte-stimulating hormone, at concentrations present in the aqueous humor (10-9 M), as well as melanocyte-stimulating hormone 11-13 (KP-D-V) reduced the invasion of cells through human fibronectin by 45%-50% and also protected uveal melanoma cells from the pro-invasive actions of tumor necrosis factor alpha. These data are consistent with inflammation playing a major role in affecting the metastatic ability of uveal melanomas. Thus, ocular microenvironments that differ in their immunosuppressive/anti-inflammatory properties may influence the invasiveness of developing tumors.
Collapse
Affiliation(s)
- Irene Cantón
- Section of Human Metabolism, Division of Clinical Sciences (North), Northern General Hospital, Sheffield S5 7AU, UK
| | | | | | | | | | | | | | | |
Collapse
|
12
|
|
13
|
|
14
|
Abstract
A case of primary ocular melanoma of the iris in a 10 year old girl is reported. Primary melanoma of the eye is exceedingly rare in childhood. The incidence and risk factors for ocular melanoma are discussed and possible reasons why this tumour is so uncommon in younger age groups are considered.
Collapse
Affiliation(s)
- D G Stanford
- Sydney Melanoma Unit, Royal Prince Alfred Hospital, New South Wales, Australia
| | | | | |
Collapse
|
15
|
Grin-Jorgensen C, Berke A, Grin M. Ocular melanoma. Dermatol Clin 1992; 10:663-8. [PMID: 1395150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Ocular melanomas are the most common intraocular malignancy in adults. The majority of ocular melanomas are choroidal melanomas. These tumors can be difficult to diagnose, especially when they are small. Documented growth of a lesion on serial examinations is the most important clinical feature favoring the diagnosis of a choroidal melanoma. Diagnostic studies including ultrasonography and angiography may be helpful in the diagnosis of these tumors. A number of treatment options are available for choroidal melanomas. These include photocoagulation, radiation therapy, local tumor resection, and enucleation.
Collapse
Affiliation(s)
- C Grin-Jorgensen
- Department of Medicine, University of Connecticut School of Medicine, Farmington
| | | | | |
Collapse
|
16
|
Kersten RC, Tse DT, Anderson RL. Diffuse malignant melanoma of iris with metastases. Surv Ophthalmol 1991; 35:403. [PMID: 2038723 DOI: 10.1016/0039-6257(91)90200-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
|
17
|
MILLER WW, BORLEY WE. A TECHNIQUE FOR REMOVAL OF IRIS MELANOMAS: IRIDOCYCLECTOMY. Trans Pac Coast Otoophthalmol Soc Annu Meet 1964; 45:223-40. [PMID: 14269927] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/26/2023]
|
18
|
LINNIK LF. [ IRIS NEOPLASMS AND THEIR SURGICAL TREATMENT]. Oftalmol Zh 1964; 19:271-8. [PMID: 14187702] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]
|
19
|
OISHI S, ONISHI C, FUJITSU M. [Case of idiopathic red iris tumor]. Rinsho Ganka 1962; 16:1019-22. [PMID: 13939718] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/24/2023]
|
20
|
BURSTEIN F. Implantation cyst simulating iris tumor. Report of a case. J Newark Beth Isr Hosp 1962; 13:226-30. [PMID: 13875041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/24/2023]
|
21
|
MAWAS J. [Contribution to the study of muscular tumors of the iris]. Ann Ocul (Paris) 1962; 195:557-8. [PMID: 14471616] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
|
22
|
MAWAS J. [Tumors of the peripheral nerves of the iris]. Ann Ocul (Paris) 1962; 195:572-3. [PMID: 14471617] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
|
23
|
VANCEA P, VAIGHEL V, BALAN R. Prim�res Sarkom der Iris. Graefes Arch Clin Exp Ophthalmol 1962; 164:421-32. [PMID: 13924672 DOI: 10.1007/bf00682197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
24
|
|
25
|
LITRICIN O. [On the problem of hyperplasia and tumors of the pigment epithelium of the iris]. Klin Monbl Augenheilkd Augenarztl Fortbild 1961; 139:249-55. [PMID: 14465867] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
|
26
|
SASSO B. [Dermoid cyst of the iris]. Klin Monbl Augenheilkd Augenarztl Fortbild 1961; 139:247-9. [PMID: 14497378] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
|
27
|
KREMLICKA L. [Metastatic carcinoma of the iris]. Cesk Oftalmol 1961; 17:141-7. [PMID: 13754247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/24/2023]
|
28
|
TOST M. [Pathological-anatomical and histotopochemical studies on a melanocytoblastoma of the iris root and of the ciliary body]. Ber Zusammenkunft Dtsch Ophthalmol Ges 1961; 63:439-41. [PMID: 13922098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/24/2023]
|
29
|
SAFAR K. [Pseudo-melanoblastoma of the iris simulated by a large thrombus]. Klin Monbl Augenheilkd Augenarztl Fortbild 1961; 139:835-8. [PMID: 14495967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
|
30
|
TOST M. [Pathological-anatomical and histotopochemical studies on a ring-form melanocytoblastoma of the iris root and ciliary body]. Z Mikrosk Anat Forsch 1961; 67:202-17. [PMID: 13777649] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/24/2023]
|
31
|
MUELLER HK, SOELLNER F, LUND OE. [Experiences in surgical removal of tumors of the iris root and ciliary body]. Ber Zusammenkunft Dtsch Ophthalmol Ges 1961; 63:194-9. [PMID: 14476899] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
|
32
|
SAFAR K. [Melanoblastoma of the iris root surgically treated with electrocoagulation]. Ber Zusammenkunft Dtsch Ophthalmol Ges 1961; 63:190-3. [PMID: 14038894] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]
|
33
|
BUERKI E. [On a sarcoma of the iris in an infant]. Opt Acta (Lond) 1961; 142:487-99. [PMID: 13874456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/24/2023]
|
34
|
BABEL J. [The nature of tumors of the iris]. Bull Soc Ophtalmol Fr 1960; 10:589-94. [PMID: 13685530] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/23/2023]
|
35
|
BALDRIDGE M. Malignant melanoma of the iris. Tex State J Med 1960; 56:865-7. [PMID: 13686279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/23/2023]
|
36
|
VALDAGNI C. [Iris metastasis from cancer of the lung]. Minerva Fisioter Radiobiol 1960; 5:228-32. [PMID: 13779680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/24/2023]
|
37
|
KOTELIANSKII EO. [An experimental model of tumors of the iris]. Vopr Onkol 1960; 6(12):53-7. [PMID: 13753474] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/24/2023]
|
38
|
MIETTINEN P, MEURMAN L. Nevus of the iris as a cause of absolute glaucoma. Ann Med Exp Biol Fenn 1960; 38:334-7. [PMID: 13770433] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/24/2023]
|
39
|
OSTACHOWICZ M. [Congenital free cyst of the iris]. Klin Oczna 1960; 30:107-10. [PMID: 14429273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/26/2023]
|
40
|
WEIGELIN E, LUND OE. [A neurogenic iris tumor after perforating eye injury]. Klin Monbl Augenheilkd Augenarztl Fortbild 1960; 136:406-11. [PMID: 13843489] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/24/2023]
|
41
|
HAGEDOORN A, SALIM I. Iridoma Irides and Nevi of the Iris and Anterior Border Layer. Am J Ophthalmol 1959; 48:825-33. [PMID: 14398776 DOI: 10.1016/0002-9394(59)90630-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
42
|
REESE AB, CLEASBY GW. The treatment of iris melanoma. Trans Am Acad Ophthalmol Otolaryngol 1959; 63:296-304; discussion 304-5. [PMID: 13659562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/23/2023]
|
43
|
REESE AB, CLEASBY GW. The treatment of iris melanoma. Am J Ophthalmol 1959; 47:118-25. [PMID: 13649850] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/23/2023]
|
44
|
GLINTERNIK SA. [Leimyoma of the iris]. Vopr Klin Lecheniia Zlokachestvennykh Novoobraz 1959; 6:55-73. [PMID: 13706070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/23/2023]
|
45
|
TOST M. [A neurogenic tumor of the iris; histochemical studies on a rare iris tumor]. Z Arztl Fortbild (Jena) 1958; 52:979-83. [PMID: 13648475] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/23/2023]
|
46
|
|
47
|
|
48
|
CHAMS G, SADOUGHI G. [Malignant melanoma of the iris]. Acta Med Iran 1958; 2:47-51. [PMID: 13582578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/23/2023] Open
|
49
|
MAYER LL, NASSAR JG. Metastatic carcinoma of the iris. Am J Ophthalmol 1958; 45:707-12. [PMID: 13533487 DOI: 10.1016/0002-9394(58)92180-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
50
|
BAKBARDIN IV. [Treatment of primary tumors of the iris]. Vestn Oftalmol 1958; 71:44-6. [PMID: 13557526] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/23/2023]
|